Chandipura viral glycoprotein (CNV-G) promotes Gectosome generation and enables delivery of intracellular therapeutics
Molecular Therapy · 2024
DOI: 10.1016/j.ymthe.2024.04.034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Therapy, 2024. Verfasst von Xiaojuan Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, University of Colorado, Boulder, CO 80303, USA. Hauptthemen laut MEDLINE: Vesiculovirus. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, NIGMS NIH HHS, NINDS NIH HHS.
Abstract (Originalsprache)
Overexpression of vesicular stomatitis virus G protein (VSV-G) elevates the secretion of EVs known as gectosomes, which contain VSV-G. Such vesicles can be engineered to deliver therapeutic macromolecules. We investigated viral glycoproteins from several viruses for their potential in gectosome production and intracellular cargo delivery. Expression of the viral glycoprotein (viral glycoprotein from the Chandipura virus [CNV-G]) from the human neurotropic pathogen Chandipura virus in 293T cells significantly augments the production of CNV-G-containing gectosomes. In comparison with VSV-G gectosomes, CNV-G gectosomes exhibit heightened selectivity toward specific cell types, including primary cells and tumor cell lines. Consistent with the differential tropism between CNV-G and VSV-G gectosomes, cellular entry of CNV-G gectosome is independent of the Low-density lipoprotein receptor, which is essential for VSV-G entry, and shows varying sensitivity to pharmacological modulators. CNV-G gectosomes efficiently deliver diverse intracellular cargos for genomic modification or responses to stimuli in vitro and in the brain of mice in vivo utilizing a split GFP and chemical-induced dimerization system. Pharmacokinetics and biodistribution analyses support CNV-G gectosomes as a versatile platform for delivering macromolecular therapeutics intracellularly.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, University of Colorado, Boulder, CO 80303, USA.
- Department of Psychology & Neuroscience, and The Center for Neuroscience, University of Colorado, Boulder, CO 80309, USA.
- Department of Chemical and Biological Engineering, University of Colorado, Boulder, CO 80309, USA; Materials Science & Engineering Program, University of Colorado, Boulder, CO 80309, USA; BioFrontiers Institute, Univers…
- Department of Biochemistry, University of Colorado, Boulder, CO 80303, USA. Electronic address: xuedong.liu@colorado.edu.
Förderung
- NIH HHS
- NIGMS NIH HHS
- NINDS NIH HHS
- NHLBI NIH HHS
- NIDA NIH HHS
- National Center for Research Resources
- National Institutes of Health
Zitieren
APA
Zhang, X., Xu, Q., Liu, Z., Ball, J. B., Black, B., Ganguly, S., Harland, M. E., Blackman, S., Bryant, S., Anseth, K., Watkins, L., & Liu, X. (2024). Chandipura viral glycoprotein (CNV-G) promotes Gectosome generation and enables delivery of intracellular therapeutics. Molecular Therapy. https://doi.org/10.1016/j.ymthe.2024.04.034
Vancouver
Zhang X, Xu Q, Liu Z, Ball JB, Black B, Ganguly S, et al. Chandipura viral glycoprotein (CNV-G) promotes Gectosome generation and enables delivery of intracellular therapeutics. Molecular Therapy. 2024. doi:10.1016/j.ymthe.2024.04.034
BibTeX
@article{Zhang2024,
author = {Zhang, Xiaojuan and Xu, Quanbin and Liu, Zeyu and Ball, Jayson B and Black, Brandon and Ganguly, Saheli and Harland, Michael E and Blackman, Samuel and Bryant, Stephanie and Anseth, Kristi and Watkins, Linda and Liu, Xuedong},
title = {Chandipura viral glycoprotein (CNV-G) promotes Gectosome generation and enables delivery of intracellular therapeutics},
journal = {Molecular Therapy},
year = {2024},
doi = {10.1016/j.ymthe.2024.04.034}
}
EUVIMED